Global Renal Osteodystrophy Market Research and Forecast, 2018-2023
Renal osteodystrophy is a bone disease which occurs when kidneys are not able to maintain proper levels of calcium and phosphorous in the blood. It is more prevalent in the people living with kidney diseases and having regular dialysis. It is also prevalent in children which causes slow bone growth and deformities along with short stature. Renal osteodystrophy market is augmenting due to increasing kidney failure incidences all across the globe. It is due to the unhealthy lifestyle of the people such as consumption of alcohol and tobacco that increase the chances of kidney failure. It can be treated by medication and in worst cases when kidney doesn’t function it is cured by dialysis or a kidney transplant. Cost of dialysis and kidney transplant are high which act as a major restraint of the market.
By geography, global renal osteodystrophy market has been divided into North America, Europe, Asia-Pacific and Rest of the World. North America is estimated to hold a significant share in the global renal osteodystrophy market. As per the American Kidney Fund, more than 31 million people in the US had chronic kidney diseases in 2015. Moreover, Asia-Pacific is estimated to be growing at a considerable rate during the forecast period owing to the rising prevalence of renal chronic disease in the region and increasing lifestyle-related diseases in the region. Major economies contributing to the growth of the market in the Asia-Pacific region are China, India, and Japan.
Key players of the renal osteodystrophy market are Abbott Laboratories Inc., AbbVie Inc., Amgen Inc., Asahi Kasei Corporation, Baxter International Inc, and DaVita Inc., among others. These companies are studied with different aspects in order to get information about strategies adopted by them in recent time. Major activities that the companies are implementing in renal osteodystrophy market are merger and acquisition, product launch, and others.
RESEARCH METHODOLOGY
The market study of global renal osteodystrophy market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
SECONDARY SOURCES INCLUDE:
The report is intended for researchers in the healthcare segment, drug discovery companies, medical equipment companies, investing firms, government organizations for overall market analysis and competitive analysis. The report provides in-depth analysis on market size, growth opportunity in the market, and product types. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.
MARKET SEGMENTATION:
Global renal osteodystrophy market is segmented on the basis of various regions and segments:
Global Renal Osteodystrophy Market Research and Analysis by Diagnosis Method
Global Renal Osteodystrophy Market Research and Analysis by Treatment.
Global Renal Osteodystrophy Market Research and Analysis by Region
THE REPORT COVERS:
By geography, global renal osteodystrophy market has been divided into North America, Europe, Asia-Pacific and Rest of the World. North America is estimated to hold a significant share in the global renal osteodystrophy market. As per the American Kidney Fund, more than 31 million people in the US had chronic kidney diseases in 2015. Moreover, Asia-Pacific is estimated to be growing at a considerable rate during the forecast period owing to the rising prevalence of renal chronic disease in the region and increasing lifestyle-related diseases in the region. Major economies contributing to the growth of the market in the Asia-Pacific region are China, India, and Japan.
Key players of the renal osteodystrophy market are Abbott Laboratories Inc., AbbVie Inc., Amgen Inc., Asahi Kasei Corporation, Baxter International Inc, and DaVita Inc., among others. These companies are studied with different aspects in order to get information about strategies adopted by them in recent time. Major activities that the companies are implementing in renal osteodystrophy market are merger and acquisition, product launch, and others.
RESEARCH METHODOLOGY
The market study of global renal osteodystrophy market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
SECONDARY SOURCES INCLUDE:
- Financial reports of the major market players
- Company websites and their product catalogue
- Geographical location of major market players.
- The average cost of renal osteodystrophy diagnosis and treatment
The report is intended for researchers in the healthcare segment, drug discovery companies, medical equipment companies, investing firms, government organizations for overall market analysis and competitive analysis. The report provides in-depth analysis on market size, growth opportunity in the market, and product types. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.
MARKET SEGMENTATION:
Global renal osteodystrophy market is segmented on the basis of various regions and segments:
Global Renal Osteodystrophy Market Research and Analysis by Diagnosis Method
Global Renal Osteodystrophy Market Research and Analysis by Treatment.
Global Renal Osteodystrophy Market Research and Analysis by Region
THE REPORT COVERS:
- Comprehensive research methodology of global renal osteodystrophy market
- Analysis of regional regulations and other government policies impacting the global renal osteodystrophy market
- Insights about market determinants which are stimulating the global renal osteodystrophy market
- Detailed and extensive market segments with regional distribution of forecasted revenues
- Extensive profiles and recent developments of market players
CHAPTER 1. REPORT SUMMARY
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders
CHAPTER 2. MARKET OVERVIEW AND INSIGHTS
2.1. Definition
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendation
2.2.3. Conclusion
2.3. Rules & Regulations
CHAPTER 3. MARKET DETERMINANTS
3.1. Motivators
3.1.1. High Prevalence of Kidney Failure and Increasing Pool of Dialysis Patient
3.1.2. Increasing Habit of Tabaco & Alcohol Consumption Causing Higher Chances of Kidney Related Problem
3.1.3. Increasing Population Pool with Diabetes and High Blood Pressure Patients
3.2. Restraints
3.2.1. High Cost of Kidney Transplants
3.2.2. Lack of Kidney Transplants Due to Unavailability of Donors
3.3. Opportunities
3.3.1. Innovation in Drug Development, Subsequent Technological Advancements & Pipeline Product
CHAPTER 4. MARKET SEGMENTATION
4.1. Global Renal Osteodystrophy Market by Diagnosis Method
4.1.1. Bone Biopsy
4.1.2. Blood Test
4.2. Global Renal Osteodystrophy Market by Treatment
4.2.1. Hemodialysis
4.2.2. Kidney Transplantation
4.2.3. Medication (Cinacalcet, Rocaltrol)
4.2.4. Parathyroidectomy
CHAPTER 5. COMPETITIVE LANDSCAPE
5.1. Key Company Analysis
5.2. Key Strategy Analysis
CHAPTER 6. REGIONAL ANALYSIS
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. RoE
6.3. Asia-Pacific
6.3.1. India
6.3.2. China
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of The World
CHAPTER 7. COMPANY PROFILES
7.1. Abbott Laboratories Inc.
7.2. AbbVie Inc.
7.3. Acologix, Inc.
7.4. Amgen Inc.
7.5. Asahi Kasei Corporation
7.6. B. Braun Melsungen AG
7.7. Baxter International Inc.
7.8. DaVita Inc.
7.9. Nikkiso Co., Ltd.
7.10. Nipro Corp.
7.11. NxStage Medical, Inc.
7.12. Rockwell Medical Inc.
7.13. Teleflex Inc.
7.14. Toray Industries, Inc.
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders
CHAPTER 2. MARKET OVERVIEW AND INSIGHTS
2.1. Definition
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendation
2.2.3. Conclusion
2.3. Rules & Regulations
CHAPTER 3. MARKET DETERMINANTS
3.1. Motivators
3.1.1. High Prevalence of Kidney Failure and Increasing Pool of Dialysis Patient
3.1.2. Increasing Habit of Tabaco & Alcohol Consumption Causing Higher Chances of Kidney Related Problem
3.1.3. Increasing Population Pool with Diabetes and High Blood Pressure Patients
3.2. Restraints
3.2.1. High Cost of Kidney Transplants
3.2.2. Lack of Kidney Transplants Due to Unavailability of Donors
3.3. Opportunities
3.3.1. Innovation in Drug Development, Subsequent Technological Advancements & Pipeline Product
CHAPTER 4. MARKET SEGMENTATION
4.1. Global Renal Osteodystrophy Market by Diagnosis Method
4.1.1. Bone Biopsy
4.1.2. Blood Test
4.2. Global Renal Osteodystrophy Market by Treatment
4.2.1. Hemodialysis
4.2.2. Kidney Transplantation
4.2.3. Medication (Cinacalcet, Rocaltrol)
4.2.4. Parathyroidectomy
CHAPTER 5. COMPETITIVE LANDSCAPE
5.1. Key Company Analysis
5.2. Key Strategy Analysis
CHAPTER 6. REGIONAL ANALYSIS
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. RoE
6.3. Asia-Pacific
6.3.1. India
6.3.2. China
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of The World
CHAPTER 7. COMPANY PROFILES
7.1. Abbott Laboratories Inc.
7.2. AbbVie Inc.
7.3. Acologix, Inc.
7.4. Amgen Inc.
7.5. Asahi Kasei Corporation
7.6. B. Braun Melsungen AG
7.7. Baxter International Inc.
7.8. DaVita Inc.
7.9. Nikkiso Co., Ltd.
7.10. Nipro Corp.
7.11. NxStage Medical, Inc.
7.12. Rockwell Medical Inc.
7.13. Teleflex Inc.
7.14. Toray Industries, Inc.
LIST OF TABLES
TABLE # 1 GLOBAL RENAL OSTEODYSTROPHY MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS METHOD 2017-2023 ($ MILLION)
TABLE # 2 GLOBAL BONE BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 3 GLOBAL BLOOD TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 4 GLOBAL RENAL OSTEODYSTROPHY MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023 ($ MILLION)
TABLE # 5 GLOBAL HEMODIALYSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 6 GLOBAL KIDNEY TRANSPLANTATION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 7 GLOBAL MEDICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 8 GLOBAL PARATHYROIDECTOMY MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 9 GLOBAL RENAL OSTEODYSTROPHY MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE # 10 NORTH AMERICA RENAL OSTEODYSTROPHY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 11 NORTH AMERICA RENAL OSTEODYSTROPHY MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS METHOD, 2017-2023 ($ MILLION)
TABLE # 12 NORTH AMERICA RENAL OSTEODYSTROPHY MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023 ($ MILLION)
TABLE # 13 EUROPE RENAL OSTEODYSTROPHY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 14 EUROPE RENAL OSTEODYSTROPHY MARKET RESEARCH AND ANALYSIS BY, DIAGNOSIS METHOD 2017-2023 ($ MILLION)
TABLE # 15 EUROPE RENAL OSTEODYSTROPHY MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023 ($ MILLION)
TABLE # 16 ASIA-PACIFIC RENAL OSTEODYSTROPHY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 17 ASIA-PACIFIC RENAL OSTEODYSTROPHY MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS METHOD, 2017-2023 ($ MILLION)
TABLE # 18 ASIA-PACIFIC RENAL OSTEODYSTROPHY MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023 ($ MILLION)
TABLE # 19 REST OF THE WORLD RENAL OSTEODYSTROPHY MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS METHOD, 2017-2023 ($ MILLION)
TABLE # 20 REST OF THE WORLD RENAL OSTEODYSTROPHY MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023 ($ MILLION)
TABLE # 1 GLOBAL RENAL OSTEODYSTROPHY MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS METHOD 2017-2023 ($ MILLION)
TABLE # 2 GLOBAL BONE BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 3 GLOBAL BLOOD TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 4 GLOBAL RENAL OSTEODYSTROPHY MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023 ($ MILLION)
TABLE # 5 GLOBAL HEMODIALYSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 6 GLOBAL KIDNEY TRANSPLANTATION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 7 GLOBAL MEDICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 8 GLOBAL PARATHYROIDECTOMY MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 9 GLOBAL RENAL OSTEODYSTROPHY MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE # 10 NORTH AMERICA RENAL OSTEODYSTROPHY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 11 NORTH AMERICA RENAL OSTEODYSTROPHY MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS METHOD, 2017-2023 ($ MILLION)
TABLE # 12 NORTH AMERICA RENAL OSTEODYSTROPHY MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023 ($ MILLION)
TABLE # 13 EUROPE RENAL OSTEODYSTROPHY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 14 EUROPE RENAL OSTEODYSTROPHY MARKET RESEARCH AND ANALYSIS BY, DIAGNOSIS METHOD 2017-2023 ($ MILLION)
TABLE # 15 EUROPE RENAL OSTEODYSTROPHY MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023 ($ MILLION)
TABLE # 16 ASIA-PACIFIC RENAL OSTEODYSTROPHY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 17 ASIA-PACIFIC RENAL OSTEODYSTROPHY MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS METHOD, 2017-2023 ($ MILLION)
TABLE # 18 ASIA-PACIFIC RENAL OSTEODYSTROPHY MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023 ($ MILLION)
TABLE # 19 REST OF THE WORLD RENAL OSTEODYSTROPHY MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS METHOD, 2017-2023 ($ MILLION)
TABLE # 20 REST OF THE WORLD RENAL OSTEODYSTROPHY MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023 ($ MILLION)
LIST OF FIGURES
FIGURE # 1 GLOBAL RENAL OSTEODYSTROPHY MARKET SHARE BY DIAGNOSIS METHOD, 2017 VS 2023 (%)
FIGURE # 2 GLOBAL RENAL OSTEODYSTROPHY MARKET SHARE BY TREATMENT, 2017 VS 2023 (%)
FIGURE # 3 GLOBAL RENAL OSTEODYSTROPHY MARKET SHARE BY GEOGRAPHY, 2017 VS 2023 (%)
FIGURE # 4 US RENAL OSTEODYSTROPHY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 5 CANADA RENAL OSTEODYSTROPHY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 6 UK RENAL OSTEODYSTROPHY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 7 FRANCE RENAL OSTEODYSTROPHY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 8 GERMANY RENAL OSTEODYSTROPHY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 9 ITALY RENAL OSTEODYSTROPHY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 10 SPAIN RENAL OSTEODYSTROPHY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 11 ROE RENAL OSTEODYSTROPHY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 12 INDIA RENAL OSTEODYSTROPHY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 13 CHINA RENAL OSTEODYSTROPHY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 14 JAPAN RENAL OSTEODYSTROPHY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 15 REST OF ASIA-PACIFIC RENAL OSTEODYSTROPHY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 16 REST OF THE WORLD RENAL OSTEODYSTROPHY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 1 GLOBAL RENAL OSTEODYSTROPHY MARKET SHARE BY DIAGNOSIS METHOD, 2017 VS 2023 (%)
FIGURE # 2 GLOBAL RENAL OSTEODYSTROPHY MARKET SHARE BY TREATMENT, 2017 VS 2023 (%)
FIGURE # 3 GLOBAL RENAL OSTEODYSTROPHY MARKET SHARE BY GEOGRAPHY, 2017 VS 2023 (%)
FIGURE # 4 US RENAL OSTEODYSTROPHY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 5 CANADA RENAL OSTEODYSTROPHY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 6 UK RENAL OSTEODYSTROPHY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 7 FRANCE RENAL OSTEODYSTROPHY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 8 GERMANY RENAL OSTEODYSTROPHY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 9 ITALY RENAL OSTEODYSTROPHY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 10 SPAIN RENAL OSTEODYSTROPHY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 11 ROE RENAL OSTEODYSTROPHY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 12 INDIA RENAL OSTEODYSTROPHY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 13 CHINA RENAL OSTEODYSTROPHY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 14 JAPAN RENAL OSTEODYSTROPHY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 15 REST OF ASIA-PACIFIC RENAL OSTEODYSTROPHY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 16 REST OF THE WORLD RENAL OSTEODYSTROPHY MARKET SIZE, 2017-2023 ($ MILLION)
